Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Post by FactFinder1994on Oct 16, 2015 4:02pm
252 Views
Post# 24199768

How many more won't get a second chance

How many more won't get a second chanceIf you take the million cases of sepsis annually in the USA as found in the Spectral Investor Presentation, and then take the 175,000 patients with severe sepsis or septic shock that have high EAA levels (found on page 14). Now apply the 20% suggested reduction in absolute mortality (found on page 13) for the PMX treated patients and that gets you to 35,000 people dying annually in the USA that could be walking around today grateful for the second chance at life. That is approximately 96 people per day, or 4 people per hour. Every 15 minutes an American dies having not received this proven/safe EAA&PMX theranostic treatment. In Japan and Italy PMX has safely and effectively been making a difference in the lives of many for several years and yet Americans continue to be denied this life saving treatment. Over 150,000 PMX filters (Toray provided) have been used over the last two decades with no reported safety issues. How could anyone support or possibly justify delaying the availability of this medical lifesaving treatment to American families any longer?
Bullboard Posts